Clinical trial
S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast…
NCT00127205 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00127205 |
|---|---|
| Title | S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer. |
| Official title | Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH North Central Cancer Treatment Group Eastern Cooperative Oncology Group NSABP Foundation Inc Cancer and Leukemia Group B NCIC Clinical Trials Group |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | clodronate disodium, ibandronate sodium, zoledronic acid |
| Enrollment | 6,097 |
| Start date | Jul 1, 2005 |
| Primary completion | Dec 1, 2017 |
| Completion | Mar 29, 2021 |
| First posted | Aug 5, 2005 |
| Last update posted | Jul 2, 2021 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: